Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...
According to the press release statement, distributions will no longer be made under previous ATM program prospectus supplements, including the one dated May 2, 2025. Sprott Asset Management LP, a ...
The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...
Strive (ASST), a publicly traded bitcoin BTC $89,524.02 treasury and asset-management company, said it arranged a $500 million at-the-market offering (ATM) for its Variable Rate Series A Perpetual ...
Abstract: The optimal power flow (OPF) problem of active distribution network (ADN) is a stochastic, nonconvex, and nonlinear problem. Although several algorithms have been presented to solve this ...
A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...